JonathanR.SwansonMDMSc, MBA

Neonat/Perinatology • Charlottesville, VA

Professor of Pediatrics, University of Virginia School of Medicine; Director, Division of Neonatology; Chief Quality Officer for Children's Services, University of Virginia Children's Hospital

Join to view full profile

Dr. Swanson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Swanson's full profile

Already have an account?

Office
1215 Hospital Dr
Charlottesville, VA 22908
Phone+1 434-924-5428

Fax+1 434-982-3759

Education & Training

University of ArizonaMBA, Health Care Administration, 2021 - 2023
Thomas Jefferson UniversityMS, Healthcare Quality & Safety, 2011 - 2013
University of Virginia Medical CenterFellowship, Neonatal-Perinatal Medicine, 2005 - 2008
University of Virginia Medical CenterResidency, Pediatrics, 2002 - 2005
University of Rochester School of Medicine and DentistryClass of 2002

Certifications & Licensure

VA State Medical License 2011 - 2026
NJ State Medical License 2008 - 2013
American Board of Pediatrics Neonatal-Perinatal Medicine

Awards, Honors, & Recognition

Fellow (FAAP) American Academy of Pediatrics

Clinical Trials

Prenatal Consult With Illustrated Literature Start of enrollment: 2017 Jun 05
Completed
Not Applicable
Gravitas Feeding Tube System Placement Validation in Neonates Start of enrollment: 2023 Oct 27
Recruiting
Not Applicable
A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact Start of enrollment: 2020 Mar 04
Active, not recruiting
Phase 2
Aerosolized Infasurf Treatment Protocol: Aerosolized Infasurf for Spontaneously Breathing Patients With Early RDS (AERO-03)
No longer available
Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients Start of enrollment: 2017 Mar 29
Completed
Phase 3
Feeding During Ibuprofen or Indomethacin Treatment of Preterm Infants Start of enrollment: 2008 Jul 01
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Correction: Perinatal risk factors associated with acute kidney injury severity and duration among infants born extremely preterm.
Keia Sanderson, Russell Griffin, Nekayla Anderson, Andrew M South, Jonathan R Swanson
Pediatric Research. 2024-09-01
Perinatal risk factors associated with acute kidney injury severity and duration among infants born extremely preterm.
Keia Sanderson, Russell Griffin, Nekayla Anderson, Andrew M South, Jonathan R Swanson
Pediatric Research. 2024-08-01
3 citations
A Deep Intronic PKHD1 Variant Identified by SpliceAI in a Deceased Neonate With Autosomal Recessive Polycystic Kidney Disease.
Felix Richter, Kayleigh D Rutherford, Anisha J Cooke, Malorie Meshkati, Vanessa Eddy-Abrams
American Journal of Kidney Diseases. 2024-06-01

Journal Articles

Association Between Early Caffeine Citrate Administration and Risk of Acute Kidney Injury in Preterm Neonates
Jennifer R Charlton, J Bryan Carmody, Matthew W Harer, David J Askenazi, Ronnie Guillet, David T Selewski, Jonathan R Swanson, JAMA
Risk Factors for Invasive Fungal Infection in Premature Infants: Enhancing a Targeted Prevention Approach
Swanson JR, Gurka MJ, Kaufman DA, J Ped Infect Dis Soc, 3/2014

Press Mentions

Fluconazole Cost-Effective in Treatment of Neonatal Invasive CandidiasisFebruary 26th, 2016
New Study Shows Prolacta's Human Milk-Based Nutritional Fortifiers Save Hospital NICUs up to $3.4M AnnuallyJune 29th, 2023